Background: Non-alcoholic fatty liver disease(NAFLD) has a high prevalence in the general population worldwide. Both triglycerides (TG) and total cholesterol (TC) are correlated with the prevalence of NAFLD. The study purpose is to determine whether TG/TC is an effective method to screen NAFLD in the general Chinese population.Methods: 93,449 subjects with average age of 43.7 ± 14.3 years were included in this cross-sectional study. Multiple logistic regressions and receiver operator characteristic curve (ROC) analyses were performed.Results: Among these subjects, 16,138 (42.7%) men and 9,591 (17.2%) women were diagnosed with NAFLD. Subjects in the higher quartiles of TG/TC had a higher prevalence of NAFLD. After adjusting multiple confounding factors, the odds ratio (OR) for NAFLD in the highest compared with the lowest quartile was 4.08 (95%CI 3.64, 4.57) in men and 4.65 (95%CI 4.14, 5.21) in women. Moreover, ROC analyses suggested TG/TC showed high diagnostic ability for detecting NAFLD, and the areas under the curves (AUC) in men and women were 0.920 (95%CI 0.917, 0.923) and 0.863 (95%CI 0.859, 0.867), respectively. Furthermore, the diagnostic ability was significantly higher in younger age groups. The AUC in 18–34 and 35–44 years group were 0.943 (95%CI 0.939, 0.946) and 0.921 (95%CI 0.917, 0.925), respectively. Besides, the women and the young people had a greater negative predictive values (90.84% for women, 93.13% for aged 18–34).Conclusion: TG/TC shows a high diagnostic accuracy for identifying NAFLD in young women, providing an important clue to establish a new tool to screen NAFLD particularly in Chinese young females.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.